Phase II Study of Dasatinib in Patients with Previously Treated Malignant Mesothelioma (Cancer and Leukemia Group B 30601): A Brief Report

Authors

Keywords

Journal

Volume 7, Issue 4, Pages 755-759

Publisher

Elsevier BV

Online

2012-03-16

DOI

10.1097/jto.0b013e318248242c

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now